- NSE
- CAPLIPOINT
- BSE
- 524742
- ISIN
- INE475E01026
CAPLIN POINT LAB
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹2,502.50
+₹120.00 (+5.04%)
NSE close ·
CAPLIN POINT LAB closed at ₹2,502.50 on 9 Nov 2026, up 5.04% on the day, and is up 29.50% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹1,504.80 to ₹2,867.40.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹19,022 Cr
- Industry P/E
- 35.5
- Dividend yield
- 0.32%
Market cap and yield at the 9 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹644 Cr | ₹179 Cr | — | ₹23.21 |
Armor risk check
CAPLIN POINT LAB moves about 2× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is CAPLIN POINT LAB's share price today?
CAPLIN POINT LAB (NSE: CAPLIPOINT) closed at ₹2,502.50 on 9 Nov 2026, up 5.04% from the previous close of ₹2,382.50. It traded between ₹2,457.00 and ₹2,597.50 that day.
What are CAPLIN POINT LAB's 52-week high and low?
Over the last 52 weeks CAPLIN POINT LAB traded between ₹1,500.30 and ₹2,990.00, adjusted for splits and bonuses.
What are CAPLIN POINT LAB's NSE symbol, BSE code and ISIN?
CAPLIN POINT LAB has NSE symbol CAPLIPOINT, BSE code 524742, ISIN INE475E01026.
How has CAPLIN POINT LAB performed over 1, 3 and 5 years?
CAPLIN POINT LAB's share price return: 1Y +29.50%, 3Y +31.26% a year, 5Y +23.91% a year. Dividends are not included.
Does CAPLIN POINT LAB pay a dividend?
Yes. CAPLIN POINT LAB's latest dividend went ex on 18 Sep 2026: Final · ₹4.00 per share. Dividends over the past year come to a yield of 0.32% at the latest close.
What is CAPLIN POINT LAB's market cap?
CAPLIN POINT LAB's market cap is ₹19,022 Cr at the close on 9 Nov 2026.
Which sector is CAPLIN POINT LAB in?
CAPLIN POINT LAB is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how CAPLIN POINT LAB fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app